Ken Yoon

Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services.

Vive Crop Protection, Inc. develops crop protection products. The firm specializes in crop protection, delivery, agronomy, formulations chemistry, polymer chemistry, chemical engineering, industrial manufacturing development and patents. Its products include AZteroid, Bifender and Fenstro. The company was founded in 2006 and is headquartered in Toronto, Canada.

Founded in 1982, VenGrowth Capital Partners, Inc. is a private equity and venture capital firm located in Toronto, Ontario. The firm is a subsidiary of Covington Capital Corp. They manage retail and institutional assets.

Deloitte Corporate Finance, Inc. provides financial, accounting, tax, and other business services. The company also offers audit, financial advisory, and consulting services through locations across the country. It is located in Toronto, Canada.

Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.

Cura-Can Health Corp. offers cannabis and hemp based product development and associated clinical services. The company is headquartered in Calgary, Canada.

The Royal Canadian Institute for Science operates as a Canadian institute for science.